Zealand Pharma, a biotech company specializing in metabolic health, announced that its CFO Henriette Wennicke and CSO Utpal Singh will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York on June 3, 2026. The discussion will focus on the company’s advancements in obesity and metabolic health treatments, leveraging their peptide research and AI-driven data platform. This event highlights Zealand Pharma’s ongoing commitment to innovation and collaboration in the biotech sector. A live webcast will be available for investors and interested parties, with a recording accessible on the company’s website after the event.
Diginex Limited has extended the Long Stop Date for its proposed acquisition of Resulticks from October 30 to November 19, 2026, allowing more time to meet closing conditions. The company also announced an extraordinary general meeting on November 20...
LayerZero has completed its integration with AnubisChain, allowing projects on AnubisChain to use LayerZero's Omnichain Fungible Token (OFT) standard. This enables the creation and management of tokens that can operate across multiple blockchain netw...
As of October 31, USDD had 1.5 billion tokens circulating with $2.21 billion in reserves, achieving a 146.99% collateralization ratio. The average daily minting volume increased by 10.5% from September, while USDD Earn's total value locked on BNB Cha...
A group of 159 addresses on Hyperliquid raised their net long exposure by about $43.17 million across 27 stock, ETF, and index-related instruments between the prior U.S. stock-market open and November 6. During this period, they added approximately $...
On November 6, Coinbase's spot order book revealed $15.7 million more buy orders than sell orders for Bitcoin, with buy orders totaling $24.94 million and sell orders at $9.24 million, while Bitcoin traded at $75,747. Binance also had more buy orders...
